You are here: Industry Insights > SARS-CoV-2

News List

ImmunityBio reports positive data from Covid-19 vaccine trial pharmaceutical-technology
November 11, 2020
ImmunityBio has reported positive study results for its novel vaccine candidate, hAd5-COVID-19, which showed memory T-cell recall from patients previously infected with SARS-CoV-2, a virus that causes Covid-19.
Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine prnasia
November 10, 2020
The rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for Swiss Rockets AG. A Basel-based subsidiary, RocketVax AG, was founded to utilize innovative Swiss technologies and expertise to achieve this goal.
Pre-existing coronavirus antibodies could help protect children against new pandemic strain worldpharmanews
November 10, 2020
Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target SARS-CoV-2 and may confer a degree of protection ...
Llama nanobodies could be a powerful weapon against COVID-19 worldpharmanews
November 10, 2020
The researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to ...
Pre-existing antibodies may protect some people against COVID-19: Study expresspharma
November 10, 2020
Researchers found that some people, notably children, have antibodies reactive to the novel coronavirus SARS-CoV-2 in their blood, despite not ever having being infected with the virus.
Celltrion presents data for COVID-19 monoclonal antibody treatment candidate CT-P59 expresspharma
November 09, 2020
It demonstrated promising safety, tolerability, antiviral effect, and efficacy profile of CT-P59 in patients with mild symptoms of COVID-19.
FDA Announces Potential for False Positive Results with Antigen Tests for Rapid Detection of SARS-CoV-2 americanpharmaceuticalreview
November 06, 2020
The U.S. Food and Drug Administration (FDA) is alerting clinical laboratory staff and health care providers that false positive results can occur with antigen tests, including when users do not follow the instructions for use of antigen tests for the ...
Cancer treatment could be replicated for COVID-19 worldpharmanews
November 06, 2020
Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists.
Scientists identify synthetic mini-antibody to combat COVID-19 worldpharmanews
November 06, 2020
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2.
Equine polyclonal antibodies have shown higher potency in in-vitro studies of SARS-CoV-2 virus neutralisation expresspharma
November 05, 2020
Bharat Serums and Vaccines has initiated a research project to co-develop an equine polyclonal antibody, alongwith NIV, against COVID-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page